• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[老年人光化性角化病的治疗]

[Treatment of actinic keratoses in older adults].

作者信息

Szeimies R-M, Stege H

机构信息

Klinikum Vest, Dorstener Str. 151, 45657, Recklinghausen, Deutschland.

Klinikum Lippe, Detmold, Deutschland.

出版信息

Dermatologie (Heidelb). 2023 Sep;74(9):663-669. doi: 10.1007/s00105-023-05208-4. Epub 2023 Aug 18.

DOI:10.1007/s00105-023-05208-4
PMID:37594513
Abstract

Actinic keratoses (AKs) are common precancerous skin lesions that primarily affect older adults due to cumulative sun exposure. Given the increased vulnerability of older adults to developing AKs, appropriate therapeutic strategies are crucial to prevent their progression to invasive squamous cell carcinoma. This comprehensive review aims to explore the various treatment modalities available for AKs in the elderly population, focusing on their efficacy, safety, and suitability for this specific age group. The article discusses topical treatments, cryotherapy, photodynamic therapy, chemical peels, and surgical interventions, providing a detailed analysis of their mechanisms of action, benefits, limitations, and considerations in geriatric patients. Furthermore, the importance of individualized treatment plans, considering factors such as comorbidities, medication interactions, and patient preferences, are highlighted.

摘要

光化性角化病(AKs)是常见的癌前皮肤病变,主要因长期累积日晒影响老年人。鉴于老年人患AKs的易感性增加,适当的治疗策略对于预防其进展为浸润性鳞状细胞癌至关重要。这篇综述旨在探讨老年人群中AKs可用的各种治疗方式,重点关注其疗效、安全性以及对该特定年龄组的适用性。文章讨论了局部治疗、冷冻疗法、光动力疗法、化学剥脱术和手术干预,详细分析了它们的作用机制、益处、局限性以及老年患者的注意事项。此外,强调了制定个体化治疗方案的重要性,需考虑合并症、药物相互作用和患者偏好等因素。

相似文献

1
[Treatment of actinic keratoses in older adults].[老年人光化性角化病的治疗]
Dermatologie (Heidelb). 2023 Sep;74(9):663-669. doi: 10.1007/s00105-023-05208-4. Epub 2023 Aug 18.
2
Therapeutic strategies for actinic keratoses--a systematic review.光化性角化病的治疗策略——系统评价。
Eur J Dermatol. 2013 Jan-Feb;23(1):14-32. doi: 10.1684/ejd.2013.1923.
3
Optimal treatment of actinic keratoses.光化性角化病的最佳治疗方法。
Clin Interv Aging. 2013;8:29-35. doi: 10.2147/CIA.S31930. Epub 2013 Jan 14.
4
[A plethora of choices: treating actinic keratoses].选择众多:治疗光化性角化病
Rev Med Suisse. 2020 Apr 1;16(688):646-650.
5
[Diagnosis and treatment of actinic keratosis].[光化性角化病的诊断与治疗]
Duodecim. 2015;131(9):863-70.
6
Pharmacotherapy of actinic keratosis: an update.光化性角化病的药物治疗:更新。
Expert Opin Pharmacother. 2012 Sep;13(13):1847-71. doi: 10.1517/14656566.2012.716039.
7
Non-melanoma Skin Cancer in Canada Chapter 3: Management of Actinic Keratoses.加拿大的非黑色素瘤皮肤癌 第3章:光化性角化病的管理
J Cutan Med Surg. 2015 May-Jun;19(3):227-38. doi: 10.1177/1203475415583414. Epub 2015 Apr 29.
8
Current therapies for actinic keratosis.光化性角化病的现行疗法。
Int J Dermatol. 2020 Jun;59(6):677-684. doi: 10.1111/ijd.14767. Epub 2020 Feb 3.
9
Management of patients with actinic keratoses.光化性角化病患者的管理
Br J Nurs. 2012;21(10):S27-30. doi: 10.12968/bjon.2012.21.Sup10.S27.
10
Chemical Peels as Field Therapy for Actinic Keratoses: A Systematic Review.化学换肤术作为光化性角化病的现场治疗:一项系统评价
Dermatol Surg. 2021 Oct 1;47(10):1343-1346. doi: 10.1097/DSS.0000000000003144.

引用本文的文献

1
Effective Treatment of Cornu Cutaneum With Pachaieruvai: A Traditional Siddha Medicine.用帕恰伊鲁瓦伊有效治疗皮角:一种传统悉达医学。
Cureus. 2025 Mar 28;17(3):e81326. doi: 10.7759/cureus.81326. eCollection 2025 Mar.

本文引用的文献

1
Poor Adherence to Self-Applied Topical Drug Treatment Is a Common Source of Low Lesion Clearance in Patients with Actinic Keratosis-A Cross-Sectional Study.日光性角化病患者自我应用外用药物治疗依从性差是皮损清除率低的常见原因——一项横断面研究
J Clin Med. 2023 Jun 1;12(11):3813. doi: 10.3390/jcm12113813.
2
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project.专家关于促进光化性角化病长期个体化管理方法的建议:光化性角化病个体化治疗(PAKT)项目。
Acta Derm Venereol. 2023 Jun 8;103:adv6229. doi: 10.2340/actadv.v103.6229.
3
Fully home-based methyl aminolevulinate daylight photodynamic therapy for actinic keratosis of the face or scalp: A real life open study.
全家居甲基氨基酮戊酸日光光动力疗法治疗面部或头皮光化性角化病:一项真实世界的开放性研究。
Dermatol Ther. 2022 Nov;35(11):e15879. doi: 10.1111/dth.15879. Epub 2022 Oct 11.
4
[Actinic keratoses : Current guideline and practical recommendations].[光化性角化病:当前指南及实用建议]
Hautarzt. 2020 Jun;71(6):463-475. doi: 10.1007/s00105-020-04619-x.
5
Patient-centered management of actinic keratosis. Results of a multi-center clinical consensus analyzing non-melanoma skin cancer patient profiles and field-treatment strategies.光化性角化病的以患者为中心的管理。多中心临床共识分析非黑素瘤皮肤癌患者特征和局部治疗策略的结果。
J Dermatolog Treat. 2020 Sep;31(6):576-582. doi: 10.1080/09546634.2019.1679335. Epub 2019 Oct 23.
6
Methyl aminolevulinate daylight photodynamic therapy applied at home for non-hyperkeratotic actinic keratosis of the face or scalp: an open, interventional study conducted in Germany.甲氨基酮戊酸光动力疗法在家中用于治疗面部或头皮非过度角化性光化性角化病:一项在德国进行的开放性、干预性研究。
J Eur Acad Dermatol Venereol. 2019 Apr;33(4):661-666. doi: 10.1111/jdv.15422. Epub 2019 Feb 22.
7
The natural history of actinic keratosis: a systematic review.光化性角化病自然病史的系统评价。
Br J Dermatol. 2013 Sep;169(3):502-18. doi: 10.1111/bjd.12420.
8
Interventions for actinic keratoses.光化性角化病的干预措施。
Cochrane Database Syst Rev. 2012 Dec 12;12(12):CD004415. doi: 10.1002/14651858.CD004415.pub2.
9
Dual mechanism of action of ingenol mebutate gel for topical treatment of actinic keratoses: rapid lesion necrosis followed by lesion-specific immune response.英诺皮肤活化剂凝胶治疗光化性角化病的双重作用机制:快速病变坏死和随后的病变特异性免疫应答。
J Am Acad Dermatol. 2012 Mar;66(3):486-93. doi: 10.1016/j.jaad.2010.12.038. Epub 2011 Nov 4.
10
Development of a treatment algorithm for actinic keratoses: a European Consensus.光化性角化病治疗算法的制定:一项欧洲共识。
Eur J Dermatol. 2008 Nov-Dec;18(6):651-9. doi: 10.1684/ejd.2008.0514. Epub 2008 Oct 27.